RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML) trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy tested for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis is an early-stage study to test the safety and find the right dose of an experimental cell therapy called CT0991. It will involve up to 24 adults whose acute myeloid leukemia has come back or has not responded to previous treatments. The main goal is to see how well patients…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Phase: PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New experimental therapy tested for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis is an early-stage study to test the safety and find the right dose of an experimental cell therapy called CT1390B. It will enroll up to 18 adults whose acute myeloid leukemia has come back or hasn't responded to standard treatments. The main goal is to see if the treatment i…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC